Literature DB >> 22198721

GWAS-linked GAK locus in Parkinson's disease in Han Chinese and meta-analysis.

Nan-Nan Li1, Xue-Li Chang, Xue-Ye Mao, Jin-Hong Zhang, Dong-Mei Zhao, Eng-King Tan, Rong Peng.   

Abstract

Genome-wide association studies of Parkinson's disease (PD) have recently identified a new susceptibility locus GAK (PARK17) (rs1564282 variant) in subjects of European ancestry. Its role in other races is still unclear. The potential differences of the clinical characteristics between carriers and non-carriers have not been examined in detail. Using a case-control methodology, we analyzed the GAK rs1564282 variant in an ethnic Han Chinese population and conducted a meta-analysis combining our result and available published data. A total of 1,574 ethnic Han Chinese study subjects comprising 812 sporadic PD patients and 762 control individuals were included. The minor allele frequency was significantly different at SNP rs1564282 between the cases and the controls (OR = 1.59, 95% CI = 1.09, 1.69, P = 0.007) in the overall PD population. Subjects with CT + TT genotypes have an increased risk (OR = 1.34, 95% CI = 1.05, 1.72, P = 0.017) compared to those with CC genotype. A meta-analysis revealed that the frequency of carrier's genotypes was significantly higher in PD than in control subjects (OR = 1.31, 95% CI = 1.19, 1.44, P < 0.00001). The gender, age of onset, Hoehn-Yahr stage and UPDRS scores and clinical features were similar between carriers and non-carriers. In conclusion, we demonstrated that the rs1564282 variant in GAK (PARK17) increases the risk of PD in Han Chinese patients from mainland China and the meta-analysis with European populations revealed a similar finding. However, carriers cannot be distinguished from non-carriers based on their clinical features or motor severity. Functional studies of GAK to unravel its role in the pathophysiologic pathway of PD will be useful.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22198721     DOI: 10.1007/s00439-011-1133-3

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  20 in total

1.  GAK, a regulator of clathrin-mediated membrane trafficking, localizes not only in the cytoplasm but also in the nucleus.

Authors:  Jun Sato; Hiroyuki Shimizu; Takashi Kasama; Norikazu Yabuta; Hiroshi Nojima
Journal:  Genes Cells       Date:  2009-04-15       Impact factor: 1.891

2.  Replication of GWAS associations for GAK and MAPT in Parkinson's disease.

Authors:  Shannon L Rhodes; Janet S Sinsheimer; Yvette Bordelon; Jeff M Bronstein; Beate Ritz
Journal:  Ann Hum Genet       Date:  2010-11-08       Impact factor: 1.670

3.  High-resolution whole-genome association study of Parkinson disease.

Authors:  Demetrius M Maraganore; Mariza de Andrade; Timothy G Lesnick; Kari J Strain; Matthew J Farrer; Walter A Rocca; P V Krishna Pant; Kelly A Frazer; David R Cox; Dennis G Ballinger
Journal:  Am J Hum Genet       Date:  2005-09-09       Impact factor: 11.025

4.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

5.  Cyclin-G-associated kinase modifies α-synuclein expression levels and toxicity in Parkinson's disease: results from the GenePD Study.

Authors:  Alexandra Dumitriu; Chris D Pacheco; Jemma B Wilk; Katherine E Strathearn; Jeanne C Latourelle; Stefano Goldwurm; Gianni Pezzoli; Jean-Christophe Rochet; Susan Lindquist; Richard H Myers
Journal:  Hum Mol Genet       Date:  2011-01-21       Impact factor: 6.150

6.  GAK, a regulator of clathrin-mediated membrane traffic, also controls centrosome integrity and chromosome congression.

Authors:  Hiroyuki Shimizu; Ippei Nagamori; Norikazu Yabuta; Hiroshi Nojima
Journal:  J Cell Sci       Date:  2009-08-04       Impact factor: 5.285

7.  Genome-wide association study identifies candidate genes for Parkinson's disease in an Ashkenazi Jewish population.

Authors:  Xinmin Liu; Rong Cheng; Miguel Verbitsky; Sergey Kisselev; Andrew Browne; Helen Mejia-Sanatana; Elan D Louis; Lucien J Cote; Howard Andrews; Cheryl Waters; Blair Ford; Steven Frucht; Stanley Fahn; Karen Marder; Lorraine N Clark; Joseph H Lee
Journal:  BMC Med Genet       Date:  2011-08-03       Impact factor: 2.103

8.  Genome-wide association study reveals genetic risk underlying Parkinson's disease.

Authors:  Javier Simón-Sánchez; Claudia Schulte; Jose M Bras; Manu Sharma; J Raphael Gibbs; Daniela Berg; Coro Paisan-Ruiz; Peter Lichtner; Sonja W Scholz; Dena G Hernandez; Rejko Krüger; Monica Federoff; Christine Klein; Alison Goate; Joel Perlmutter; Michael Bonin; Michael A Nalls; Thomas Illig; Christian Gieger; Henry Houlden; Michael Steffens; Michael S Okun; Brad A Racette; Mark R Cookson; Kelly D Foote; Hubert H Fernandez; Bryan J Traynor; Stefan Schreiber; Sampath Arepalli; Ryan Zonozi; Katrina Gwinn; Marcel van der Brug; Grisel Lopez; Stephen J Chanock; Arthur Schatzkin; Yikyung Park; Albert Hollenbeck; Jianjun Gao; Xuemei Huang; Nick W Wood; Delia Lorenz; Günther Deuschl; Honglei Chen; Olaf Riess; John A Hardy; Andrew B Singleton; Thomas Gasser
Journal:  Nat Genet       Date:  2009-11-15       Impact factor: 38.330

9.  Genomewide association study for onset age in Parkinson disease.

Authors:  Jeanne C Latourelle; Nathan Pankratz; Alexandra Dumitriu; Jemma B Wilk; Stefano Goldwurm; Gianni Pezzoli; Claudio B Mariani; Anita L DeStefano; Cheryl Halter; James F Gusella; William C Nichols; Richard H Myers; Tatiana Foroud
Journal:  BMC Med Genet       Date:  2009-09-22       Impact factor: 2.103

10.  Genomewide association study for susceptibility genes contributing to familial Parkinson disease.

Authors:  Nathan Pankratz; Jemma B Wilk; Jeanne C Latourelle; Anita L DeStefano; Cheryl Halter; Elizabeth W Pugh; Kimberly F Doheny; James F Gusella; William C Nichols; Tatiana Foroud; Richard H Myers
Journal:  Hum Genet       Date:  2008-11-06       Impact factor: 4.132

View more
  6 in total

Review 1.  Endocytic membrane trafficking and neurodegenerative disease.

Authors:  Andrea M A Schreij; Edward A Fon; Peter S McPherson
Journal:  Cell Mol Life Sci       Date:  2015-12-31       Impact factor: 9.261

2.  The Potential Mutation of GAK Gene in the Typical Sporadic Parkinson's Disease from the Han Population of Chinese Mainland.

Authors:  Jie Zhang; Hanyi Zeng; Lei Zhu; Libing Deng; Xin Fang; Xia Deng; Huiting Liang; Chunyan Tang; Xuebing Cao; Yi Lu; Jiao Li; Xiao Ren; Wenjie Zuo; Xiong Zhang; Renshi Xu
Journal:  Mol Neurobiol       Date:  2015-12-17       Impact factor: 5.590

3.  Genetic variations of GAK in two Chinese Parkinson's disease populations: a case-control study.

Authors:  Wei-En Johnny Tseng; Chiung-Mei Chen; Yi-Chun Chen; Zhao Yi; Eng-King Tan; Yih-Ru Wu
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

4.  Association of LRRK2 R1628P variant with Parkinson's disease in Ethnic Han-Chinese and subgroup population.

Authors:  Pei Zhang; Qingzhi Wang; Fengjuan Jiao; Jianguo Yan; Lijun Chen; Feng He; Qian Zhang; Bo Tian
Journal:  Sci Rep       Date:  2016-11-04       Impact factor: 4.379

Review 5.  J protein mutations and resulting proteostasis collapse.

Authors:  Carolina Koutras; Janice E A Braun
Journal:  Front Cell Neurosci       Date:  2014-07-08       Impact factor: 5.505

6.  Interaction between SNCA, LRRK2 and GAK increases susceptibility to Parkinson's disease in a Chinese population.

Authors:  Wen-Juan Yu; Lan Cheng; Nan-Nan Li; Ling Wang; Eng-King Tan; Rong Peng
Journal:  eNeurologicalSci       Date:  2015-08-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.